Evaluation of hematopoietic stem cell mobilization following DHAP(C) ± rituximab in relapsed or refractory lymphomas. // Transfusion and Apheresis Science. – URL: https://www.sciencedirect.com/science/article/pii/S1473050226001953?dgcid=rss_sd_all
Evaluation of hematopoietic stem cell mobilization following DHAP(C) ± rituximab in relapsed or refractory lymphomas. Transfusion and Apheresis Science. https://www.sciencedirect.com/science/article/pii/S1473050226001953?dgcid=rss_sd_all
“Evaluation of hematopoietic stem cell mobilization following DHAP(C) ± rituximab in relapsed or refractory lymphomas.” Transfusion and Apheresis Science.
@article{article69924,
title = {Evaluation of hematopoietic stem cell mobilization following DHAP(C) ± rituximab in relapsed or refractory lymphomas},
journal = {Transfusion and Apheresis Science},
url = {https://www.sciencedirect.com/science/article/pii/S1473050226001953?dgcid=rss_sd_all}
}